Philip D. Cotter, PhD, FACMG, FFSc (RCPA)
Principal, ResearchDx

Dr Cotter is a Principal and Co-Founder of ResearchDx, and Laboratory Director of Pacific Diagnostics Clinical Laboratory, Irvine, CA, a subsidiary of ResearchDx. Dr Cotter received his doctorate in Biomedical Sciences from the Department of Human Genetics at the Mount Sinai School of Medicine in New York. He is Board Certified by the American Board of Medical Genetics in both Clinical Cytogenetics and Clinical Molecular Genetics, is a Fellow of the American College of Medical Genetics, Fellow of the Faculty of Science Royal College of Pathologists of Australasia and Associate Clinical Professor of Pediatrics at the University of California San Francisco.
Dr Cotter’s experience includes Vice President and Laboratory Director at Biocept Inc. in San Diego, Laboratory Director at the Illumina Clinical Services Laboratory in San Diego, Laboratory Director at Combimatrix Molecular Diagnostics in Irvine, Director of Molecular Cytogenetics at the Mount Sinai School of Medicine in New York, Director of Cytogenetics and Molecular Genetics at the Children’s Hospital and Research Center in Oakland CA, and Director of Advanced Molecular Diagnostics at US Labs in Irvine, CA. Dr Cotter has published extensively in the areas of cytogenetics, molecular genetics, oncology and prenatal diagnosis.
Mathew W. Moore, PhD
Principal, ResearchDx

Principal and Co-Founder of ResearchDx, Dr. Mathew William Moore is a renowned leader in the field of molecular diagnostic development. A seasoned industry expert and technology advocate, Dr Moore has served as Vice President of Research and Development of Neogenomics Inc (A leading esoteric oncology clinical laboratory) from 2006 to 2011. Prior to that, Dr. Moore served as Vice President of Research and Development for CombiMatrix Molecular Diagnostics, Inc., where he was responsible for the oncology, and developmental disorders programs. Previously he served as Senior Scientist with US Labs, a division of Laboratory Corporation of America (LabCorp) and as Director of Product development at Response Genetics.
Dr. Moore received his Bachelors of Science degree in Biotechnology, graduating with honors. Dr. Moore received his Ph.D. in Biotechnology from the University of New South Wales in Sydney, Australia.
